Beneficial effects of testosterone therapy on obesity, CV risk and mortality in type 2 diabetes

Description


 

Speakers

Prof. Dr. Hugh Jones

Hugh Jones
Centre for Diabetes & Endocrinology,
Barnsley Hospital NHS Foundation Trust &
Academic Unit of Diabetes,
Endocrinology & Metabolism,
University of Sheffield, UK

References

  • Groti K, Zuran I, Antonic B, Forsnaric L, Pfeifer M. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. The aging male : the official journal of the International Society for the Study of the Aging Male. 2018;21(3):158-169. Return to content